Replies to post #557980 on NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Always on the side taking the longer over the shorter approach.

Milton Friedman explained how the regulators did far more harm than good, He suggested leaving the industry to follow the law of supply and demand, and making those responsible for causing harms accountable. Bad actors would curve their appetite for risk taking, while the motive to make profits would advance innovation faster. Would the scheme remove potential harms to patients? No, but far less than the system at large today, while helping a much greater proportion of patients benefit than currently possible.

ILT

[SkyLimit2022]

No, I did not look at that excerpt at all actually. I am looking at it from a broad perspective. For me, MRAs simply support the fact that those regulatory agencies are highly respected by the FDA and an approval by any one of the listed agencies would be significant and meaningful to the others with whom there exists an agreement (MRA).

https://www.fda.gov/international-programs/international-arrangements/mutual-recognition-agreement-mra

https://static.nice.org.uk/NICE%20strategy%202021%20to%202026%20-%20Dynamic,%20Collaborative,%20Excellent.pdf

https://www.nice.org.uk/guidance/indevelopment/gid-ta10143

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847